Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms
Clinical trial NCT00487708 · COMPLETED
Trial details
- NCT number
- NCT00487708
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2008-07-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.